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Mortality rates after rupture of an abdominal
aortic aneurysm range from 30% to 70% and remain
unchanged despite aggressive supportive care.1 In a
recent review Huber et al2 reported that the sys-
temic inflammatory response syndrome (SIRS) lead-
ing to multiple organ dysfunction (MOD) account-
ed for 57% of mortality in patients undergoing
infrarenal aortic reconstruction, with hepatic failure
being the initiating event in 43% of these cases.
Hepatic dysfunction was also found to be a good
predictor of mortality after ruptured abdominal aor-
tic aneurysm in a recent series reported by Maziak et
al.3 It seems that hepatic function becomes deficient
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Purpose: Hepatic dysfunction may contribute to death from multiple organ dysfunction
after abdominal aortic surgery. Several factors are likely responsible, and the purpose of
this study was to determine whether the cytokines tumor necrosis factor-a (TNF-a ) and
interleukin 1 (IL-1) are involved in initiating this remote hepatic injury.
Methods: In a normotensive rat model of 4-hour bilateral hindlimb ischemia/reperfusion
(I/R), we measured systemic TNF-a and IL-1 levels throughout the I/R period. Rats
were randomly assigned to either the 3-hour control group, the 3-hour I/R group, or
the I/R group with administration of a polyclonal antibody (PAb) to TNF-a (I/R +
TNF-a PAb). Direct evidence of lethal hepatocyte injury through the labeling of nuclei
by propidium iodide (per 10–1mm3) and altered microvascular perfusion were assessed
by using intravital microscopy.
Results: Systemic TNF-a peaked at 83.97 pg/mL (P < .05, n = 5) at 30 minutes of reper-
fusion and returned to baseline in 60 to 90 minutes. No significant change in systemic
IL-1 was detected (P < .05, n = 4). Alanine aminotransferase increased 2.5-fold in the
I/R group through 3 hours of reperfusion (P < .05, n = 4), and TNF-a PAb did not
attenuate this alanine aminotransferase increase (P < .05, n = 6). Lethal hepatocyte
injury increased by 8-fold in the I/R group compared with the control group (P < .05,
n = 5), whereas TNF-a PAb significantly reduced this injury (P < .05, n = 4). No region-
al differences in injury were noted within the acinus. Total perfusion within the
microvascular unit did not drop; however, significant flow heterogeneity was observed.
The proportion of continuously perfused sinusoids declined in the I/R group after 3
hours of reperfusion in both periportal (62.0 ± 2.2, P < .05) and, to a lesser, although
significant, degree, in the pericentral regions (73.2 ± 1.73, P < .05).
Conclusion: By scavenging extracellular TNF-a with a PAb, we provide direct evidence
that TNF-a contributes to, but is not solely responsible for, early remote hepatocellular
injury and microvascular dysfunction. The administration of TNF-a PAb reduced lethal
hepatocyte injury in both regions of the acinus and also improved perfusion in the peri-
portal region (76.8 ± 5.41, P < .05), but not in the pericentral region. This suggests that
TNF- a released during reperfusion mediates early remote hepatocellular injury and
microvascular dysfunction after a remote ischemic insult. (J Vasc Surg 1999;30:533-41.)
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in patients with SIRS and MOD after aortic recon-
structive surgery, and although support mechanisms
exist for various other organs, it is difficult to sup-
port the failing liver. Thus treatment must be direct-
ed at preventing or limiting progression of hepatic
dysfunction in these patients. It is therefore essential
that we understand mechanisms leading to the initi-
ation and progression of such injury.
There is evidence to support the hypothesis that
ischemia/reperfusion (I/R) injury to one organ
causes injury in remote organs. Such remote injury
has been demonstrated in the lung4 and intestine,5,6
and our laboratory has recently shown that hepatic
injury and microcirculatory alterations occur in the
liver after hindlimb I/R in a rat model.7 Mechanisms
of hepatic injury after direct I/R have been studied
extensively; however, mechanisms leading to liver
injury after a remote ischemic insult are not well
understood. Previous studies regarding hepatic
injury suggest that microcirculatory failure predis-
poses the liver to cellular injury.8,9 However, work by
our laboratory7 and others10 suggests that hepatic
microcirculatory perfusion deficits are not prerequi-
sites for hepatocellular injury after a remote insult.
Several other factors likely contribute to remote
I/R-induced hepatic injury, such as proinflammatory
cytokines, activation of Kupffer cells and/or leuko-
cytes, and reactive oxygen intermediates. The focus
of our investigation will be on the factors initiating
this injury, with particular attention being paid to the
role of cytokines. Among cytokines, tumor necrosis
factor-a (TNF-a ) is thought to be an instigator of
direct hepatic I/R injury. Support for this hypothesis
was provided when the administration of a TNF-a
antiserum pretreatment was found to reduce direct
hepatic I/R-induced injury.11 However, the anti-
serum used was likely a complex mixture of struc-
turally diverse antibodies. The use of such antisera
likely carries the potential for low selectivity.
TNF-a is produced predominantly by activated
monocytes and macrophages, and the hepatic
Kupffer cells represent the largest fixed macrophage
population in the body.12 TNF- a is released from
postischemic extremities13 and has been documented
to play a role in local limb injury, as well as remote
lung injury after bilateral hindlimb I/R.4 However,
its role in initiating liver injury after hindlimb I/R
remains unclear. Interleukin 1 (IL-1) has also been
demonstrated to be elevated after hindlimb I/R and
is implicated in remote lung injury; however, its role
in remote hepatic injury is uncertain.
The purpose of this study was to test the hypoth-
esis that increased plasma levels of cytokines, particu-
larly TNF-a and IL-1, are essential for the initiation
of remote hepatic injury after a distant focus of
inflammation. To accomplish this goal, we used a
model of hindlimb I/R developed in our laboratory
to initiate a systemic inflammatory response and an
antibody that had been shown to be highly selective
for TNF-a . Using a whole organ-to-cellular approach
in conjunction with antibody therapy to selected
cytokines, we provide direct evidence supporting a
role for TNF- a , but not IL-1, in the initiation of
remote organ injury.
METHODS
Animals. All animals (male Wistar rats, 200 to
250 g) used in this study were randomly assigned to
either the 3-hour control group (n = 5), the 3-hour
I/R group (n = 6), or the 3-hour I/R group with
administration of a polyclonal antibody (PAb; rabbit
anti-mouse cross-reactive to rat) to TNF-a (n = 4).
The experimental protocols were undertaken in
accordance with the criteria outlined by the
Canadian Council on Animal Care and approved by
the University of Western Ontario Council on
Animal Care.
Surgical procedure. Details of the surgical pro-
cedure have been described previously.7 Briefly, all
animals were anesthetized with inhalational isoflu-
rane (5% induction, 2% surgery, and 1% mainte-
nance; Abbott Laboratories). While anesthetized,
the left carotid artery was cannulated to continuous-
ly monitor arterial pressure, as well as to allow for
blood sampling and the application of fluorescent
vital dyes. The left jugular vein was also cannulated
for administration of the analgesic fentanyl citrate 
(2 m g/100 g body weight/hr). All animals were
chronically prepared by using a Harvard swivel and
fluid resuscitated with normal saline (2-4 mL/hr)
throughout the study to maintain mean arterial pres-
sures above 90 mm Hg. Bilateral hindlimb ischemia
was induced for 4 hours by the application of a
tourniquet (#4 silk, Johnson & Johnson Medical)
above the greater trochanter of each leg, which was
removed just before recovery from anesthesia.
Control animals underwent the same protocol,
except the ischemic event was omitted. The animals
receiving TNF-a PAb underwent a similar protocol
but received antibodies to TNF-a (3.5 · 104 neu-
tralizing units/100 g body weight administered
intravascularly), as described by Haagmans et al,14
10 minutes before reperfusion.
Antibody to TNF-a . The antibody used in this
study was obtained from Biosource International. It
had been purified by TNF-a affinity chromatogra-
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phy and has been shown to be highly selective for
TNF-a . In addition, this antibody was shown not to
be cross-reactive with any other cytokine. The neu-
tralizing capacity of the antibody had been deter-
mined by a cytotoxicity assay, which defines one
neutralizing unit of TNF-a bioactivity as equivalent
to 50 pg of TNF-a protein.
Intravital videomicroscopy. After the 3-hour
period of limb reperfusion, animals were reanes-
thetized with isoflurane, and the left lobe of the liver
was exposed and reflected into a warmed saline bath
(37°C) on the stage of an inverted intravital micro-
scope (Diaphot-TMD, Nikon). The liver was then
covered with plastic film (Saran, Dow Chemical) to
prevent dehydration and minimize the influence of
respiratory movement. Random views (10-13) of
the microcirculation near the surface of the liver
were observed by using a 20 · objective lens (CF
Achromat 20/0.4, Nikon), which provided 600 ·
magnification at the video monitor. Illumination was
provided by fibre optic light guides (Intralux 5000,
Volpi). Images were viewed with a charge-coupled
device video camera (Dage-MTI) and recorded on
videotape for later off-line analysis by using an
SVHS video recorder (JVC). In all instances the
measurement of microvascular perfusion and lethal
hepatocellular injury were undertaken by individuals
who were unaware of the experimental group or
intervention.
Off-line video analysis of lethal hepatocyte
injury and sinusoidal perfusion. Lethally injured
hepatocytes were labeled in vivo with an intra-arter-
ial bolus of the fluorescent vital dye propidium
iodide (PI; 0.05 mg/100 g body weight) just before
limb reperfusion. Use of PI in the liver has been
shown to identify hepatocytes that undergo irre-
versible damage (ie, cell death).15 The PI fluores-
cence was viewed by using an emission barrier filter
of greater than 590 nm after excitation at 510 to
560 nm. An index of cell death was determined off-
line and expressed as the number of PI-labeled
nuclei per unit volume of tissue (10–1mm3). Lethal
hepatocyte injury was measured in both the peripor-
tal and pericentral regions of the hepatic acinus.
Sinusoidal perfusion was determined by using
accepted methods of stereological analysis, which
have been described in detail elsewhere.16,17 Briefly,
estimates of the density of sinusoids within the area
of interest was used to establish the size of a point-
counting grid, which would be used to estimate the
number of sinusoids. The total number and distance
between points in the grid was determined on the
basis of the size of the largest object of interest (ie,
sinusoidal area). Thus it was determined that for a
magnification of 600· such a grid would consist of a
6 · 6 array of points. A sinusoid was counted if a
point landed within its dimensions. Application of
this point-counting grid to the video monitor dur-
ing playback of the video recordings provided initial
estimates of sinusoidal density. On the basis of such
estimates, the total number of fields required to pro-
vide a greater than 95% confidence in the density of
sinusoids was determined. Thus 10 to 13 randomly
chosen fields of view were recorded and used for
analysis of microvascular perfusion.
Sinusoidal perfusion was designated according to
the following criteria: (1) continuously perfused
sinusoids (CPS; ie, those sinusoids that retained red
blood cell perfusion throughout the 1-minute
recording period); (2) intermittently perfused sinu-
soids (ie, those sinusoids in which red blood cell per-
fusion stopped for any period of time during the 1-
minute recording); and (3) nonperfused sinusoids
(ie, sinusoids with stationary red blood cells through-
out the recording). Each criteria was expressed as a
percentage of the total number of sinusoids counted
and measured in both the periportal and pericentral
regions of the hepatic acinus. A schematic of the
method used to determine microvascular perfusion
in the liver is provided in Fig 1.
Whole organ estimate of hepatocellular injury.
Measures of serum alanine aminotransferase (ALT)
were used to estimate global hepatocellular injury
(mild through severe). Serum ALT was measured at
three time points during the I/R protocol: (1) before
ischemia, (2) before reperfusion, and (3) at 3 hours
of reperfusion.
Serum cytokine assays. TNF-a and IL-1 levels
were measured from arterial blood samples drawn at
10 time points in separate I/R animals to obtain an
accurate profile of each cytokine’s activity during the
I/R period (TNF-a , n = 5; IL-1, n = 4): (1) preis-
chemia, (2) before reperfusion, (3) 15 minutes of
reperfusion, (4) 30 minutes of reperfusion, (5) 60
minutes of reperfusion, (6) 90 minutes of reperfu-
sion, (7) 3 hours of reperfusion, (8) 4 hours of
reperfusion, (9) 5 hours of reperfusion; and (10) 6
hours of reperfusion. Preischemic values were com-
pleted to provide the necessary internal control.
TNF-a was also measured in the TNF-a PAb group
to confirm the neutralizing capacity of the antibody.
Cytokine assays were measured by using an enzyme-
linked immunosorbent assay (ELISA; Biosource
International). The TNF-a ELISA was sensitive to
less than 4 pg/mL, whereas the IL-1 ELISA was
sensitive to less than 3 pg/mL. 
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Statistics. The main effects were determined by
using standard analysis of variance procedures, and
significant effects were then tested for individual dif-
ferences by using t tests with Bonferroni correction.
All values reported are expressed as means ± SEM.
Statistical significance was set at an a level of .05.
RESULTS
Model. After 4 hours of bilateral hindlimb
ischemia and 3 hours of reperfusion, systemic arter-
ial pressures were maintained at 90 mm Hg or
greater and did not differ between experimental
groups at any time (data not shown).
Serum cytokine levels. A significant rise in sys-
temic TNF-a was measured at 30 minutes of reper-
fusion compared with that found in the control
group (P < .05, Fig 2), which returned to baseline
by 60 minutes. No significant changes in TNF-a lev-
els occurred during the ischemic period or during
the remaining 6 hours of reperfusion. TNF-a levels
were measured in the I/R + TNF-a PAb group, and
levels were not found to be elevated above baseline
(data not shown). No significant changes in IL-1
were noted during the I/R period, although a small
rise in IL-1 was noted at 240 minutes. Only one rat
in the group had detectable levels, which resulted in
a high standard error and no statistical significance.
Elevated IL-1 levels were not detected at any other
point during the ischemia or 6-hour reperfusion
period (Fig 2).
ALT levels. Four hours of ischemia followed by
3 hours of reperfusion resulted in a significant rise in
ALT level when compared with that found in con-
trol animals (P < .05, Fig 3). Administration of the
TNF-a PAb did not significantly attenuate this rise
in ALT observed after 3 hours of reperfusion (P <
.05, Fig 3).
Cellular index of lethal hepatocellular injury.
Dead hepatocytes were labeled with the fluorescent
vital dye PI. After 3 hours of reperfusion, the I/R
animals demonstrated a significant increase in PI-
labeled hepatocytes in both periportal and pericen-
tral regions of the hepatic acinus (P < .05, Fig 4). In
the I/R + TNF-a PAb group a significant decrease
in the number of dead hepatocytes was noted after 3
hours of reperfusion (P < .05, Fig 4). No apprecia-
ble differences in lethal injury were noted between
regions of the acinus in any of the groups. 
Sinusoidal perfusion. Significant overall differ-
ences in total sinusoidal perfusion were not observed
during the reperfusion period; however, significant
flow heterogeneity was demonstrated within individ-
ual regions of the acinus. The proportion of CPS
declined significantly in the I/R group in the peri-
portal region, whereas the proportion of intermit-
tently perfused sinusoids increased (P < .05, Fig 5,
A). A similar trend was noted in the pericentral
region; however, the decline in CPS was significant-
ly less than that observed in the periportal region (P
< .05, Fig 5, B). The administration of TNF-a PAb
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Fig 1. Schematic of the method used for determining liver sinusoidal perfusion. Sinusoidal
perfusion was determined by using a point-counting grid. The total number and distance
between points was predetermined by using the size of the largest object of interest (ie, sinu-
soidal area). For a magnification of 600· , the grid would consist of a 6 · 6 array of points.
Circled points represent those that fall within the dimensions of a sinusoid. These selected
points are then evaluated for specific perfusion criteria and expressed as a proportion of the
total number of sinusoids touched by a point.
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Fig 2. Serum cytokine levels. A significant peak in systemic TNF-a occurred at 30 minutes of
reperfusion and returned to baseline by 60 minutes. No significant changes in TNF-a levels
were measured during the ischemic period or during the remaining 6 hours of reperfusion. No
significant changes in IL-1 were detected during the I/R period or at any other point during
the 6-hour reperfusion period. Data represent means ± SEM. Asterisk, Significantly greater
than any other time (P < .05).
Fig 3. Serum ALT. Four hours of ischemia followed by 3 hours of reperfusion resulted in a
significantly elevated ALT level when compared with the control group. The TNF-a PAb did
not provide any benefits to such injury at 3 hours of reperfusion. Data represent means ± SEM.
Asterisk, Significantly greater than preischemia prereperfusion levels (P < .05); hatched mark,
significantly greater than control levels (P < .05).
improved perfusion heterogeneity in the periportal
region compared with that of the I/R group (P <
.05, Fig 5, A) and appeared to improve perfusion in
the pericentral region; however, the magnitude of
the difference was not statistically significant (P <
.05, Fig 5, B).
DISCUSSION
SIRS is known to induce remote organ injury18,19
and contributes significantly to the mortality rate in
patients undergoing aortic reconstructive surgery.
Many of the common models used to study remote
hepatic injury during SIRS are subject to confound-
ing factors, such as hemorrhagic shock, or involve
direct injury to the liver through endotoxin, zymosan,
or intestinal I/R.20-22 These factors make interpreta-
tion of the causes of remote organ injury difficult. To
avoid such complications, we used a normotensive
model of bilateral hindlimb I/R previously estab-
lished in our laboratory.5,7 By preventing hypotension
and hypoxia through resuscitation, as would be done
in the clinical setting, we were able to test the mech-
anisms of remote injury without the addition of such
confounding variables.
In this study we were able to demonstrate a sys-
temic TNF-a peak during the early reperfusion peri-
od with no appreciable rise in IL-1. Because Kupffer
cells are known to be the major source of TNF-a in
the rat,12 it is likely that the liver may be a major
source of this cytokine in our model. The fact that
the liver has been implicated as the primary source of
TNF- a in septic models23 would support this
hypothesis. However, skeletal muscle washout dur-
ing reperfusion cannot be excluded because rat
skeletal muscle has been shown to express this
cytokine not only under normal conditions24 but
also after I/R.13 In addition to liver and muscle, the
contribution of other organs affected during SIRS
cannot be excluded. For example, the intestine may
have been involved because injury to this organ had
previously been demonstrated by using the same
model of remote organ injury as that used in the
present study.5
Significant levels of IL-1 were not detected in
the I/R group. However, one animal had elevated
levels after 4 hours of reperfusion. This may indicate
that we are just beginning to see the presence of IL-
1 at later time points, as suggested in the litera-
ture.25 IL-1 may play a role in the progression of
injury, but it is unlikely that it is involved in the ini-
tiation process, which was the focus of this study.
Several clinical trials studying the inhibition of
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Fig 4. Lethal hepatocyte injury (ie, cell death). I/R group animals demonstrated a significant
increase in PI-labeled hepatocytes in both periportal and pericentral regions of the hepatic aci-
nus at 3 hours of reperfusion. The TNF-a PAb significantly diminished the number of dead
hepatocytes. No appreciable differences were noted between regions of the acinus in any of the
groups. Data represent means ± SEM. Asterisk, Significantly greater than the control and I/R
+ TNF-a PAb groups (P < .05).
TNF-a in sepsis have been conducted.26,27 However,
significant beneficial effects of such treatment were
not demonstrated. Such results might be explained,
in part, by the fact that no detectable levels of TNF-
a were found at the time of antibody administra-
tion.28-30 Although such interventions may not have
been beneficial in septic patients, we were able to
identify a discrete TNF-a peak, which, when inhibit-
ed, attenuated lethal hepatocellular injury. It is likely
that the antibody used in clinical trials had been deliv-
ered after the transient spike of TNF-a and that criti-
cal components of the injury process had already been
triggered, thus limiting the usefulness of such therapy.
In this study estimates of liver injury were obtained
by using two methods: ALT and PI. ALT was used as
an estimate of whole organ injury and is specific to the
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Fig 5. Sinusoidal perfusion. No apparent differences in total sinusoidal perfusion were
observed during the reperfusion period; however, significant flow heterogeneity was demon-
strated within the individual regions of the acinus. CPS declined significantly in the I/R group
in the periportal region (A), whereas the magnitude of intermittently perfused sinusoids
increased. A similar trend was noted in the pericentral region (B); however, the decline in CPS
was significantly less. The administration of TNF-a PAb appeared to improve perfusion het-
erogeneity in both regions of the acinus. Data represent means ± SEM. Asterisk, Significantly
different than the control and I/R + TNF-a PAb groups (P < .05); hatched mark, significant-
ly different from the periportal region.
A
B
liver. However, its measure in the serum reflects a wide
spectrum of injury (ie, minor through severe). In fact,
increased serum ALT can occur as a result of injury as
minor as altered membrane permeability or as severe as
complete cell lysis. On the other hand, the fluorescent
vital dye PI gains access and labels the nuclei of only
those cells that undergo irreversible damage (ie, dead
cells).15 Thus in our study increased measures of ALT
provide evidence that a large population of cells expe-
rienced some degree of injury. Because the magnitude
of PI-labeled cells was relatively small (150-
200/10–1mm3), it is likely that such cell death reflects
a minor proportion of total cell injury. Previously, we
demonstrated that the proportion of dead hepatocytes
accounted for only a small percentage of the total
number of cells within the volume of tissue studied.7
By administering antibodies to TNF-a , we pro-
vided direct evidence that TNF- a released during
hindlimb reperfusion contributes to early, remote
cell death. It is important to note that the rise in
ALT at 3 hours was not affected by this interven-
tion, suggesting that TNF-a contributed to lethal
injury only. The precise mechanism by which TNF-
a acts is the subject of ongoing study. Evidence from
models of direct liver ischemia suggest that TNF-a
initiates early cell death by means of activation of
caspase, leading to apoptosis.31,32 The subsequent
accumulation of leukocytes has been suggested as a
mechanism leading to progression of cell death by
means of necrosis. TNF-a may injure either by acti-
vation of leukocytes directly or by activation of
endothelial cells to increase adhesiveness for leuko-
cytes.33,34 Both Kupffer cells and hepatocytes
express receptors for and may respond to TNF-a ,35
potentially leading to direct hepatocyte injury or
indirect injury mediated by Kupffer cells. Thus this
cytokine could potentially cause direct hepatocyte
injury, as well as indirect injury through activation of
various mechanisms.
Although TNF-a has been shown to influence cell
death, it is clear that it is not the sole mediator of liver
injury because its neutralization did not influence mea-
surements of ALT. Other potential factors involved in
the remote injury process may include activation of
complement36,37 or the production of reactive oxygen
metabolites.38,39 It is clear that further study regarding
these and other mechanisms is required.
Inhibition of TNF- a also had demonstrable
effects on the hepatic microvasculature. We were able
to attenuate the level of perfusion heterogeneity in
the periportal region after 3 hours of reperfusion.
Although a similar trend was measured in the peri-
central region, no statistical significance was noted.
This suggests that microvascular perfusion may be
regulated by different mechanisms in the periportal
and pericentral regions of the liver acinus. This may
be due to differences in the microvascular structure
in each region or differences in the distribution of
other cells, such as Kupffer cells or Ito cells (pericytes
involved in vascular control). The periportal region
contains the majority of the hepatic Kupffer cell pop-
ulation, and these cells may contribute to the perfu-
sion differences observed between regions.40
The mechanism whereby a discrete tissue injury
triggers a response in remote organs is elusive.
Hepatic dysfunction is common in MOD, and the
failing liver is difficult to support. Therefore under-
standing the mechanisms leading to the initiation of
hepatic injury during SIRS is critical. The interac-
tions between inflammatory mediators, such as
cytokines and resident hepatic cells, are likely
responsible for early hepatic injury and microvascu-
lar dysfunction during SIRS. By scavenging TNF-a
with a selective antibody, we provide direct evidence
that this cytokine contributes to, but is not solely
responsible for, early remote hepatocellular injury
and microvascular dysfunction. 
We thank the members of The Division of Vascular
Surgery, London Health Sciences Centre, and Michael
Carson for their helpful discussions and editorial com-
ments. We also thank Nancy Kirkvliet for conducting the
cytokine assays.
REFERENCES
1. Katz DJ, Stanley JC, Zelenock GB. Operative mortality rates
for intact and ruptured abdominal aortic aneurysms in
Michigan: an eleven-year statewide experience. J Vasc Surg
1994;19:804-15.
2. Huber TS, Harward TR, Flynn TC, Albright JL, Seeger JM.
Operative mortality rates after elective infrarenal aortic recon-
structions. J Vasc Surg 1995;22:287-93.
3. Maziak DE, Lindsay TF, Marshall JC, Walker PM. The
impact of multiple organ dysfunction on mortality following
ruptured abdominal aortic aneurysm repair. Ann Vasc Surg
1998;12:93-100.
4. Seekamp A, Warren JS, Remick DG, Till GO, Ward PA.
Requirements for tumor necrosis factor-alpha and inter-
leukin-1 in limb ischemia/reperfusion injury and associated
lung injury. Am J Pathol 1993;143:453-63.
5. Willoughby RP, Harris KA, Carson MW, et al. Intestinal
mucosal permeability to 51Cr-ethylenediamine tetraacetic
acid is increased after bilateral lower extremity ischemia-
reperfusion in the rat. Surgery 1996;120:547-53.
6. Corson RJ, Paterson IS, O’Dwyer ST, et al. Lower limb
ischaemia and reperfusion alters gut permeability. Eur J Vasc
Surg 1992;6:158-63.
7. Brock RW, Carson MW, Harris KA, Potter RF. Micro-
circulatory perfusion deficits are not essential for remote
parenchymal injury within the liver. Am J Physiol 1999;277:
G55-60.
JOURNAL OF VASCULAR SURGERY
540 Lawlor et al September 1999
8. Chun K, Zhang J, Biewer J, Ferguson D, Clemens MG.
Microcirculatory failure determines lethal hepatocyte injury
in ischemic/reperfused rat livers. Shock 1994;1:3-9.
9. Clemens MG, McDonagh PF, Chaudry IH, Baue AE.
Hepatic microcirculatory failure after ischemia and reperfu-
sion: improvement with ATP-MgCl2 treatment. Am J
Physiol 1985;248:H804-11.
10. Wang P, Ayala A, Ba ZF, Zhou M, Perrin MM, Chaudry IH.
Tumor necrosis factor-alpha produces hepatocellular dysfunc-
tion despite normal cardiac output and hepatic microcircula-
tion. Am J Physiol 1993;265:G126-32.
11. Colletti LM, Remick DG, Burtch GD, Kunkel SL, Strieter
RM, Campbell DA Jr. Role of tumor necrosis factor-alpha in
the pathophysiologic alterations after hepatic ischemia/
reperfusion injury in the rat. J Clin Invest 1990;85:
1936-43.
12. Decker K. Biologically active products of stimulated liver
macrophages (Kupffer cells). Eur J Biochem 1990;192:245-61.
13. Sternbergh WC3, Tuttle TM, Makhoul RG, Bear HD, Sobel
M, Fowler AA. Postischemic extremities exhibit immediate
release of tumor necrosis factor. J Vasc Surg 1994;20:
474-81.
14. Haagmans BL, Stals FS, van der Meide PH, Bruggeman CA,
Horzinek MC, Schijns VE. Tumor necrosis factor alpha pro-
motes replication and pathogenicity of rat cytomegalovirus. J
Virol 1994;68:2297-304.
15. Herman B, Nieminen AL, Gores GJ, Lemasters JJ.
Irreversible injury in anoxic hepatocytes precipitated by an
abrupt increase in plasma membrane permeability. FASEB J
1988;2:146-51.
16. Cruz-Orive LM, Weibel ER. Recent stereological methods for
cell biology: a brief survey. Am J Physiol 1990;258:L148-56.
17. Schmid-Schoenbein GW, Zweifach BW, Kovalcheck S. The
application of stereological principles to morphometry of the
microcirculation in different tissues. Microvasc Res 1977;14:
303-17.
18. Faist E, Baue AE, Dittmer H, Heberer G. Multiple organ
failure in polytrauma patients. J Trauma 1983;23:775-87.
19. Moore FA, Moore EE, Poggetti R, et al. Gut bacterial
translocation via the portal vein: a clinical perspective with
major torso trauma. J Trauma 1991;31:629-36.
20. Holman JM Jr, Saba TM. Hepatocyte injury during post-
operative sepsis: activated neutrophils as potential mediators.
J Leukoc Biol 1988;43:193-203.
21. van Bebber IP, Boekholtz WK, Goris RJ, et al. Neutrophil
function and lipid peroxidation in a rat model of multiple
organ failure. J Surg Res 1989;47:471-5.
22. Hill J, Lindsay T, Rusche J, Valeri CR, Shepro D, Hechtman
HB. A Mac-1 antibody reduces liver and lung injury but not
neutrophil sequestration after intestinal ischemia-reperfusion.
Surgery 1992;112:166-72.
23. Michie HR, Wilmore DW. Sepsis and tumor necrosis factor—
bedfellows that cannot be ignored. Ann Surg 1990;212:653-4.
24. Saghizadeh M, Ong JM, Garvey WT, Henry RR, Kern PA.
The expression of TNF alpha by human muscle. Relationship
to insulin resistance. J Clin Invest 1996;97:1111-6.
25. Seekamp A, Jochum M, Ziegler M, van Griensven M, Martin
M, Regel G. Cytokines and adhesion molecules in elective
and accidental trauma-related ischemia/reperfusion. J
Trauma 1998;44:874-82.
26. Fisher CJJ, Opal SM, Dhainaut JF, et al. Influence of an anti-
tumor necrosis factor monoclonal antibody on cytokine lev-
els in patients with sepsis. The CB0006 Sepsis Syndrome
Study Group. Crit Care Med 1993;21:318-27.
27. Abraham E, Wunderink R, Silverman H, et al. Efficacy and
safety of monoclonal antibody to human tumor necrosis fac-
tor alpha in patients with sepsis syndrome. A randomized,
controlled, double-blind, multicenter clinical trial. TNF-
alpha MAb Sepsis Study Group. JAMA 1995;273:934-41.
28. Ksontini R, MacKay SL, Moldawer LL. Revisiting the role of
tumor necrosis factor alpha and the response to surgical
injury and inflammation. Arch Surg 1998;133:558-67.
29. Rogy MA, Coyle SM, Oldenburg HS, et al. Persistently ele-
vated soluble tumor necrosis factor receptor and interleukin-
1 receptor antagonist levels in critically ill patients. J Am Coll
Surg 1994;178:132-8.
30. Van Zee KJ, Kohno T, Fischer E, Rock CS, Moldawer LL,
Lowry SF. Tumor necrosis factor soluble receptors circulate
during experimental and clinical inflammation and can pro-
tect against excessive tumor necrosis factor alpha in vitro and
in vivo. Proc Natl Acad Sci USA 1992;89:4845-9.
31. Jaeschke H, Fisher MA, Lawson JA, Simmons CA, Farhood
A, Jones DA. Activation of caspase 3 (CPP32)-like proteases
is essential for TNF-alpha-induced hepatic parenchymal cell
apoptosis and neutrophil-mediated necrosis in a murine
endotoxin shock model. J Immunol 1998;160:3480-6.
32. Leist M, Gantner F, Kunstle G, Wendel A. Cytokine-mediat-
ed hepatic apoptosis. Rev Physiol Biochem Pharmacol 1998;
133:109-55.
33. Welbourn R, Goldman G, O’Riordain M, et al. Role for
tumor necrosis factor as mediator of lung injury following
lower torso ischemia. J Appl Physiol 1991;70:2645-9.
34. Anderson BO, Brown JM, Harken AH. Mechanisms of neu-
trophil-mediated tissue injury. J Surg Res 1991;51:170-9.
35. Volpes R, van den Oord JJ, De Vos R, Desmet VJ. Hepatic
expression of type A and type B receptors for tumor necrosis
factor. J Hepatol 1992;14:361-9.
36. Jaeschke H, Farhood A, Bautista AP, Spolarics Z, Spitzer JJ.
Complement activates Kupffer cells and neutrophils during
reperfusion after hepatic ischemia. Am J Physiol 1993;264:
G801-9.
37. Mollnes TE, Fosse E. The complement system in trauma-
related and ischemic tissue damage: a brief review. Shock
1994;2:301-10.
38. Ward PH, Maldonado M, Vivaldi E. Oxygen-derived free
radicals mediate liver damage in rats subjected to tourniquet
shock. Free Radic Res Commun 1992;17:313-25.
39. Jaeschke H, Benzick AE, Smith CV, Mitchell JR. The patho-
physiological significance of reactive oxygen formation in rat
liver. Adv Exp Med Biol 1991;283:295-8.
40. MacPhee PJ, Schmidt EE, Groom AC. Intermittence of
blood flow in liver sinusoids, studied by high-resolution in
vivo microscopy. Am J Physiol 1995;269:G692-8.
Submitted Jan 19, 1999; accepted Apr 14, 1999.
JOURNAL OF VASCULAR SURGERY
Volume 30, Number 3 Lawlor et al 541
